Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions reflect a positive reception, with phrases like 'highlighting high spending among' and mentions of conditions such as chronic kidney disease, which underscore the significance of multimorbidity. The tone is informative and somewhat urgent, indicating an understanding of the study's potential to influence healthcare strategies and resource allocation.
Most discussions acknowledge the importance of understanding healthcare spending related to chronic multimorbidity, reflecting a general consensus supporting the research focus.
Posts show high interest by highlighting key findings and emphasizing the significance of multimorbidity in healthcare economics.
While some posts elaborate on conditions like kidney disease and liver cirrhosis, the overall engagement is moderate, with some sharing details but few deep dives into methodology.
The studies are perceived to have meaningful implications for healthcare policy and management, though there's limited evidence of calls for immediate action.
Published in @PLOSMedicine found chronic kidney disease, liver cirrhosis, ischemic heart disease, & inflammatory bowel disease are the
New @PLOSMedicine multi-morbidity study finds 56% of private health insurance consumers had
Joint study with @UniSouthDenmark & IHME published in @PLOSMedicine highlighting chronic #KidneyDisease, #LiverCirrhosis, Ischemic #HeartDisease, & #IBD as highest multimorbidity spending among private health insurance users in the US Learn more ⤵️ https://t.co/vqW6bGz3ak
Using data from over 16 million people in the United States, Angela Y Chang and colleagues explore how multimorbidity, when considering 63 different conditions, influences health care expenditure. https://t.co/3vYQS0nbBL #healthcare #economics https://t.co/QnOP1PYP1e
Estimating health spending associated with chronic multimorbidity in 2018: An observational study among adults in the United States https://t.co/0YMYqxRSys via @IHME_UW
RT @IHME_UW: New @PLOSMedicine multi-morbidity study finds 56% of private health insurance consumers had
This observational study examines healthcare spending related to chronic multimorbidity among U.S. adults in 2018, highlighting the economic impact of multiple chronic conditions.
RT @RevistaMFSamfyc: Cálculo del gasto sanitario asociado con plurimorbilidad crónica en 2018: estudio observacional entre adultos de Estad…
Cálculo del gasto sanitario asociado con plurimorbilidad crónica en 2018: estudio observacional entre adultos de Estados Unidos https://t.co/2RL4AUPzPk PMID 37014826
RT @RevistaMFSamfyc: Cálculo del gasto sanitario asociado con la plurimorbilidad crónica en 2018: estudio observacional entre adultos en Es…
Cálculo del gasto sanitario asociado con la plurimorbilidad crónica en 2018: estudio observacional entre adultos en Estados Unidos https://t.co/2RL4AUP1ZM PMID 37014826
RT @IHME_UW: Published in @PLOSMedicine found chronic kidney disease, liver cirrhosis, ischemic heart disease, & inflammatory bowel disease…
RT @IHME_UW: Published in @PLOSMedicine found chronic kidney disease, liver cirrhosis, ischemic heart disease, & inflammatory bowel disease…
Published in @PLOSMedicine found chronic kidney disease, liver cirrhosis, ischemic heart disease, & inflammatory bowel disease are the
#PLOSMedicine: Estimating health spending associated with chronic multimorbidity in 2018: An observational st ... https://t.co/i99ke8uaXh
Estimating health spending associated with chronic multimorbidity in 2018: An observational study among adults in the United States https://t.co/0YMYqxRSys via @IHME_UW
RT @IHME_UW: Joint study with @UniSouthDenmark & IHME published in @PLOSMedicine highlighting chronic #KidneyDisease, #LiverCirrhosis, Isch…
Joint study with @UniSouthDenmark & IHME published in @PLOSMedicine highlighting chronic #KidneyDisease, #LiverCirrhosis, Ischemic #HeartDisease, & #IBD as highest multimorbidity spending among private health insurance users in the US Learn more ⤵️ https://t.co/vqW6bGz3ak
Studies investigate the meaning of 'multimorbidity' and how much it costs us https://t.co/MMjj4gH9Hs https://t.co/XBzoe0JoYB https://t.co/bBktGlunKM https://t.co/A1t403aFPO
RT @IHME_UW: New @PLOSMedicine multi-morbidity study finds 56% of private health insurance consumers had
RT @IHME_UW: New @PLOSMedicine multi-morbidity study finds 56% of private health insurance consumers had
RT @IHME_UW: New @PLOSMedicine multi-morbidity study finds 56% of private health insurance consumers had
New @PLOSMedicine multi-morbidity study finds 56% of private health insurance consumers had
Using data from over 16 million people in the United States, Angela Y Chang and colleagues explore how multimorbidity, when considering 63 different conditions, influences health care expenditure. https://t.co/3vYQS0nbBL #healthcare #economics https://t.co/QnOP1PYP1e